| 1 |
35134115 | Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia. | 2022 Apr 12 |
2 |
| 2 |
35356197 | Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy. | 2022 |
1 |
| 3 |
29749441 | Apoptosis of CD19+ chimeric antigen receptor T cells after treatment with chemotherapeutic agents. | 2018 Jul |
1 |
| 4 |
25940712 | Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs. | 2015 Jun 18 |
1 |
| 5 |
22410752 | Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia. | 2012 Nov |
1 |
| 6 |
15512822 | Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect. | 2004 Nov |
3 |
| 7 |
12756020 | Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study. | 2003 Jun |
1 |
| 8 |
10515887 | In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. | 1999 Oct 15 |
1 |